Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation - PubMed (original) (raw)
Review
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation
Timo Sorsa et al. Ann Med. 2006.
Free article
Abstract
Matrix metalloproteinases (MMPs) form a family of enzymes that mediate multiple functions both in the tissue destruction and immune responses related to periodontal inflammation. The expression and activity of MMPs in non-inflamed periodontium is low but is drastically enhanced to pathologically elevated levels due to the dental plaque and infection-induced periodontal inflammation. Soft and hard tissue destruction during periodontitis and peri-implantitis are thought to reflect a cascade of events involving bacterial virulence factors/enzymes, pro-inflammatory cytokines, reactive oxygen species and MMPs. However, recent studies suggest that MMPs can also exert anti-inflammatory effects in defence of the host by processing anti-inflammatory cytokines and chemokines, as well as by regulating apoptotic and immune responses. MMP-inhibitor (MMPI)-drugs, such as doxycycline, can be used as adjunctive medication to augment both the scaling and root planing-treatment of periodontitis locally and to reduce inflammation systematically. Furthermore, MMPs present in oral fluids (gingival crevicular fluid (GCF), peri-implant sulcular fluid (PISF), mouth-rinses and saliva) can be utilized to develop new non-invasive, chair/bed-side, point-of-care diagnostics for periodontitis and dental peri-implantitis.
Similar articles
- Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis.
Kuula H, Salo T, Pirilä E, Hagström J, Luomanen M, Gutierrez-Fernandez A, Romanos GE, Sorsa T. Kuula H, et al. Arch Oral Biol. 2008 Feb;53(2):175-86. doi: 10.1016/j.archoralbio.2007.09.010. Epub 2007 Nov 9. Arch Oral Biol. 2008. PMID: 17996844 - Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation.
Nomura T, Ishii A, Shimizu H, Taguchi N, Yoshie H, Kusakari H, Hara K. Nomura T, et al. Clin Oral Implants Res. 2000 Oct;11(5):430-40. doi: 10.1034/j.1600-0501.2000.011005430.x. Clin Oral Implants Res. 2000. PMID: 11168235 - Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease.
Sorsa T, Mäntylä P, Rönkä H, Kallio P, Kallis GB, Lundqvist C, Kinane DF, Salo T, Golub LM, Teronen O, Tikanoja S. Sorsa T, et al. Ann N Y Acad Sci. 1999 Jun 30;878:130-40. doi: 10.1111/j.1749-6632.1999.tb07679.x. Ann N Y Acad Sci. 1999. PMID: 10415725 Review. - Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review.
Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MH. Preshaw PM, et al. J Clin Periodontol. 2004 Sep;31(9):697-707. doi: 10.1111/j.1600-051X.2004.00558.x. J Clin Periodontol. 2004. PMID: 15312090 Review. - Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid.
Kivelä-Rajamäki M, Maisi P, Srinivas R, Tervahartiala T, Teronen O, Husa V, Salo T, Sorsa T. Kivelä-Rajamäki M, et al. J Periodontal Res. 2003 Dec;38(6):583-90. doi: 10.1034/j.1600-0765.2003.00688.x. J Periodontal Res. 2003. PMID: 14632921
Cited by
- Host response mechanisms in periodontal diseases.
Silva N, Abusleme L, Bravo D, Dutzan N, Garcia-Sesnich J, Vernal R, Hernández M, Gamonal J. Silva N, et al. J Appl Oral Sci. 2015 May-Jun;23(3):329-55. doi: 10.1590/1678-775720140259. J Appl Oral Sci. 2015. PMID: 26221929 Free PMC article. Review. - Resistance of MMP9 and TIMP1 to endotoxin tolerance.
Muthukuru M, Cutler CW. Muthukuru M, et al. Pathog Dis. 2015 Jul;73(5):ftu003. doi: 10.1093/femspd/ftu003. Epub 2014 Dec 4. Pathog Dis. 2015. PMID: 25951835 Free PMC article. - Salivary Enzymatic Activity and Carious Experience in Children: A Cross-Sectional Study.
Vacaru RP, Didilescu AC, Constantinescu I, Mărunțelu I, Tănase M, Stanciu IA, Kaman WE, Brand HS. Vacaru RP, et al. Children (Basel). 2022 Mar 2;9(3):343. doi: 10.3390/children9030343. Children (Basel). 2022. PMID: 35327715 Free PMC article. - Association of chairside salivary aMMP-8 findings with periodontal risk assessment parameters in patients receiving supportive periodontal therapy.
Schmalz G, Kummer MK, Kottmann T, Rinke S, Haak R, Krause F, Schmidt J, Ziebolz D. Schmalz G, et al. J Periodontal Implant Sci. 2018 Aug 31;48(4):251-260. doi: 10.5051/jpis.2018.48.4.251. eCollection 2018 Aug. J Periodontal Implant Sci. 2018. PMID: 30202608 Free PMC article. - Salivary Biomarkers in Periodontitis Patients: A Pilot Study.
Reddahi S, Bouziane A, Rida S, Tligui H, Ennibi O. Reddahi S, et al. Int J Dent. 2022 Mar 24;2022:3664516. doi: 10.1155/2022/3664516. eCollection 2022. Int J Dent. 2022. PMID: 35368315 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources